Apollomics (APLM) Competitors $26.93 -3.17 (-10.53%) Closing price 04:00 PM EasternExtended Trading$25.84 -1.09 (-4.03%) As of 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock APLM vs. IZTC, UNCY, RPTX, VXRT, LITS, XBIT, HOWL, CRVO, PMVP, and COEPShould you be buying Apollomics stock or one of its competitors? The main competitors of Apollomics include Invizyne Technologies (IZTC), Unicycive Therapeutics (UNCY), Repare Therapeutics (RPTX), Vaxart (VXRT), Lite Strategy (LITS), XBiotech (XBIT), Werewolf Therapeutics (HOWL), CervoMed (CRVO), PMV Pharmaceuticals (PMVP), and Coeptis Therapeutics (COEP). These companies are all part of the "pharmaceutical products" industry. Apollomics vs. Its Competitors Invizyne Technologies Unicycive Therapeutics Repare Therapeutics Vaxart Lite Strategy XBiotech Werewolf Therapeutics CervoMed PMV Pharmaceuticals Coeptis Therapeutics Apollomics (NASDAQ:APLM) and Invizyne Technologies (NASDAQ:IZTC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends, media sentiment and valuation. Do institutionals & insiders believe in APLM or IZTC? 19.1% of Apollomics shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media favor APLM or IZTC? In the previous week, Apollomics had 20 more articles in the media than Invizyne Technologies. MarketBeat recorded 20 mentions for Apollomics and 0 mentions for Invizyne Technologies. Apollomics' average media sentiment score of 0.18 beat Invizyne Technologies' score of 0.00 indicating that Apollomics is being referred to more favorably in the media. Company Overall Sentiment Apollomics Neutral Invizyne Technologies Neutral Do analysts rate APLM or IZTC? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Apollomics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Invizyne Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is APLM or IZTC more profitable? Company Net Margins Return on Equity Return on Assets ApollomicsN/A N/A N/A Invizyne Technologies N/A N/A N/A Which has better earnings and valuation, APLM or IZTC? Invizyne Technologies has lower revenue, but higher earnings than Apollomics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApollomics$1.49M19.88-$53.86MN/AN/AInvizyne TechnologiesN/AN/AN/AN/AN/A SummaryApollomics beats Invizyne Technologies on 5 of the 5 factors compared between the two stocks. Get Apollomics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APLM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APLM vs. The Competition Export to ExcelMetricApollomicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$33.21M$3.48B$6.17B$10.69BDividend YieldN/A2.26%5.72%4.83%P/E RatioN/A23.0629.1427.22Price / Sales19.88482.28580.06129.95Price / CashN/A47.5937.5161.65Price / Book6.0110.6612.476.59Net Income-$53.86M-$52.56M$3.32B$276.14M7 Day Performance46.12%4.97%1.87%0.01%1 Month PerformanceN/A16.48%8.40%3.60%1 Year Performance96.86%14.95%63.49%32.76% Apollomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APLMApollomics0.2457 of 5 stars$26.93-10.5%N/A+135.0%$33.21M$1.49M0.0045Gap UpIZTCInvizyne TechnologiesN/A$12.95-4.1%N/AN/A$80.96MN/A0.0029Gap UpUNCYUnicycive Therapeutics2.6668 of 5 stars$4.56+1.6%$57.00+1,150.0%+16.6%$80.53M$680K-1.119RPTXRepare Therapeutics2.7759 of 5 stars$1.87+2.7%$4.50+140.6%-45.2%$80.34M$53.48M-0.72180Gap UpVXRTVaxart1.7712 of 5 stars$0.34+1.3%$2.00+482.2%-56.7%$78.64M$47.40M-1.27120News CoverageLITSLite StrategyN/A$2.19+1.9%N/AN/A$78.07M$65.30M-0.46100Positive NewsXBITXBiotech2.117 of 5 stars$2.51-2.0%N/A-67.2%$76.53M$4.01M-2.73100News CoverageShort Interest ↓HOWLWerewolf Therapeutics3.8757 of 5 stars$1.67+2.5%$8.00+379.0%-21.0%$76.37MN/A-1.0240CRVOCervoMed3.4277 of 5 stars$8.22+2.6%$19.29+134.6%-47.5%$76.04M$9.74M-3.154News CoveragePMVPPMV Pharmaceuticals2.6021 of 5 stars$1.42+7.6%$5.50+287.3%-7.0%$75.25MN/A-0.9050High Trading VolumeCOEPCoeptis Therapeutics0.7413 of 5 stars$15.53-0.1%N/A+261.3%$74.86MN/A-2.682News CoverageShort Interest ↑ Related Companies and Tools Related Companies Invizyne Technologies Competitors Unicycive Therapeutics Competitors Repare Therapeutics Competitors Vaxart Competitors Lite Strategy Competitors XBiotech Competitors Werewolf Therapeutics Competitors CervoMed Competitors PMV Pharmaceuticals Competitors Coeptis Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APLM) was last updated on 10/21/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apollomics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apollomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APLM Stock Alerts